Outcome of patients with low-risk myelodysplasia after azacitidine treatment failure

Thomas Prébet1, Sylvain Thepot, Steven D Gore

  • 1Department of Hematological Malignancies, Sidney Kimmel Cancer Center, Johns Hopkins University, Baltimore, MD, USA. prebett@ipc.unicancer.fr.

Haematologica
|September 18, 2012
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos